Biotechnology

Orakl Oncology’s co-founders, Gustave Ronteix, Diane-Laure Pagès and Fanny Jaulin.

Orakl Oncology raises €3 million to develop its techbio platform for precision oncology

Wed, 04/10/2023 - 07:30
Paris, France, 4th October 2023 / Sciad Newswire /

Laverock Therapeutics raises £13.5M to develop unique gene silencing platform for programmable advanced therapies

Thu, 28/09/2023 - 08:00
Stevenage, UK, 28th September 2023 / Sciad Newswire /

BioMap unveils a "Life Science Leaderboard" to compare AI models and reveals the advanced capabilities of its 100B-scale "xTrimo" model

Tue, 25/07/2023 - 07:30
Highlights: 

Modifying algae to make rare antioxidants in extreme environments

Thu, 06/07/2023 - 10:57
Thuwal, Saudi Arabia / Thursday 6 July, 2023 / Sciad Newswire / KAUST / In a collaborative

Orthonika awarded £1.34 million Innovate UK grant to accelerate development of its total meniscus replacement towards the clinic

Wed, 31/05/2023 - 08:00
London, UK, 31st May 2023 / Sciad Newswire / Orthonika Limit
GHS Fund 2023 Project Innovations

Connect in Pharma launches partnerships for global health innovation

Tue, 16/05/2023 - 16:26
London, UK, 16th May 2023 / Sciad Newswire / Connect in Pharma announce today that for every visitor to the 2023 Ge

Poster Presentation shows insight into Laverock Therapeutics’ platform for cell based therapeutic development

Mon, 15/05/2023 - 00:00
London, UK, 15th May 2023 / Sciad Newswire / Laverock Therapeutics Ltd today announces that a key update on its proprietary

Poster presentation demonstrates the differentiated profile and broad applicability of the company’s gene silencing platform

Mon, 15/05/2023 - 00:00
London, UK, 15th May 2023 / Sciad Newswire / Laverock Therapeutics Ltd today announces that a key update on its propriet

BRIM plans to launch a new funding round to accelerate late-stage clinical trial and initiate a new phase 2 trial for orphan drug BRM424 in the U.S

Wed, 10/05/2023 - 07:30
Taipei, Taiwan, 10th May 2023 / Sciad Newswire / BRIM Biotechnology, Inc.
PF7 machine

Flexicon’s integrated solution for Müggenburg Pharma's filling line increases capacity for high-value product

Wed, 26/04/2023 - 00:00

Pages